Skip to content

What is Ozempic? Uses, doses, cost and how to take it

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

What is Ozempic? It's semaglutide, a GLP-1 medicine from Novo Nordisk for adults with type 2 diabetes, taken as a once-weekly injection or a once-daily tablet. It's approved to improve blood sugar control and to lower cardiovascular and kidney risks. The lowest self-pay price is $199 a month for a new patient's first two fills, then $349.

Source: NovoCare self-pay

Key takeaways

  • Every approved Ozempic use is in adults with type 2 diabetes. No weight-loss use appears on its label.
  • Ozempic isn't insulin. If you use both, give them as separate injections and never mix them.
  • Paying cash? Through NovoCare Pharmacy, the pen is $349 a month for 0.25 mg, 0.5 mg or 1 mg.
  • Missed an injection? If it's been 5 days or fewer, take it as soon as possible. Otherwise, skip it.
  • Once you've started a pen, throw it away after 56 days, even if medicine is left in it.

Ozempic at a glance

Ozempic facts from the FDA label and verified prices
Active ingredientsemaglutide
MakerNovo Nordisk
FDA-approved uses
  • Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (injection and tablets)
  • Reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease (injection)
  • Reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who are at high risk for these events (tablets)
  • Reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease (injection)
Forms and strengths
  • Multi-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg): 0.25, 0.5, 1, 2 mg
  • Tablet (once daily; shares a label with Rybelsus, not substitutable mg-to-mg): 1.5, 4, 9 mg
Medicare GLP-1 BridgeNot in the Bridge
LabelRevised: 5/2026 (DailyMed version 20)

Ozempic dose schedule from the label

Multi-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg)Revised: 5/2026 (DailyMed version 20)

  1. 10.25 mg28 daysStart
  2. 20.5 mg28 daysMaintenance dose
  3. 31 mg28 daysMaintenance dose
  4. 42 mgongoingMaintenance dose

Tablet (once daily; shares a label with Rybelsus, not substitutable mg-to-mg)Revised: 5/2026 (DailyMed version 20)

  1. 11.5 mg30 daysStart
  2. 24 mg30 daysMaintenance dose
  3. 39 mgongoingMaintenance dose

Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.

See every price

Every verified Ozempic price

Ozempic: price by where you buy, form and dose
Where you buyForm · dosePriceConditionsSource
Manufacturer savings cardMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · All strengths$25/month
Conditions

Commercial insurance that covers Ozempic. Pay as little as $25 for a 1-, 2- or 3-month prescription of any pen dose, subject to a maximum savings of $100 per month, for up to 48 months. One month is one box of one pen. Government beneficiaries excluded. Eligibility and restrictions apply.

ozempic.com
TrumpRxMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 0.25 mg$199/month
Conditions

Out-of-pocket (self-pay) price on TrumpRx.gov. New self-pay patients pay $199 for the first two monthly fills of 0.25 mg or 0.5 mg (fills between 11/17/2025 and 12/31/2026), then $349 per month. Self-pay only; government beneficiaries excluded; no insurance reimbursement.

trumprx.gov
TrumpRxMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 0.5 mg$199/month
Conditions

Out-of-pocket (self-pay) price on TrumpRx.gov. New self-pay patients pay $199 for the first two monthly fills of 0.25 mg or 0.5 mg (fills between 11/17/2025 and 12/31/2026), then $349 per month. Self-pay only; government beneficiaries excluded; no insurance reimbursement.

trumprx.gov
TrumpRxMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 1 mg$349/month
Conditions

Out-of-pocket (self-pay) price on TrumpRx.gov for one month (one pen). Self-pay only; government beneficiaries excluded; no insurance reimbursement. TrumpRx lists the original price as $1,027.51.

trumprx.gov
TrumpRxMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 2 mg$499/month
Conditions

Out-of-pocket (self-pay) price on TrumpRx.gov for one month (one pen). Self-pay only; government beneficiaries excluded; no insurance reimbursement. TrumpRx lists the original price as $1,027.51.

trumprx.gov
NovoCare self-payMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 0.25 mg$199/month
Conditions

Limited-time self-pay price for patients new to the Ozempic Savings Offer or NovoCare Pharmacy: $199 per month for the first 2 monthly fills of 0.25 mg or 0.5 mg through December 31, 2026, then $349 per month. One month is one box of one pen. No insurance used; eligibility and restrictions apply.

ozempic.com
NovoCare self-payMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 0.5 mg$199/month
Conditions

Limited-time self-pay price for patients new to the Ozempic Savings Offer or NovoCare Pharmacy: $199 per month for the first 2 monthly fills of 0.25 mg or 0.5 mg through December 31, 2026, then $349 per month. One month is one box of one pen. No insurance used; eligibility and restrictions apply.

ozempic.com
NovoCare self-payMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 1 mg$349/month
Conditions

Self-pay price through NovoCare Pharmacy or the Ozempic self-pay offer at a retail pharmacy; no insurance used. One month is one box of one pen. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the offer at any time.

ozempic.com
NovoCare self-payMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 2 mg$499/month
Conditions

Self-pay price through NovoCare Pharmacy or the Ozempic self-pay offer at a retail pharmacy; no insurance used. One month is one box of one pen. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the offer at any time.

ozempic.com
Hims & HersMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · All strengths$199/month
Conditions

'From' price; medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states.

hims.com
Mochi HealthMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · All strengths$199/month
Conditions

'As low as' price; plus Mochi Health membership ($79/month, first month $0 promo for new subscribers). Medication not included in membership; availability and pricing vary by state.

joinmochi.com
SesameMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 0.25 mg$199/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). New self-pay patients only, first two consecutive months, offer valid Nov 17, 2025 - Dec 31, 2026; then $349/month.

sesamecare.com
SesameMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 0.5 mg$199/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). New self-pay patients only, first two consecutive months, offer valid Nov 17, 2025 - Dec 31, 2026; then $349/month.

sesamecare.com
SesameMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 1 mg$349/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Standard price after introductory period (also applies to 0.25 mg and 0.5 mg).

sesamecare.com
SesameMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · 2 mg$499/month
Conditions

Manufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual).

sesamecare.com
List priceMulti-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) · All strengths$1,027.51/fill
Conditions

List price per pen (one 1.5 mL pen for 0.25/0.5 mg, or one 3 mL pen for 1 mg or 2 mg). The same NovoCare page shows $997.58 in its phone-only layout block and $1,027.51 in the desktop block; the desktop figure is shown here. Novo Nordisk has announced a $675 list price effective January 1, 2027.

novocare.com

Ozempic is Novo Nordisk’s brand of semaglutide for adults with type 2 diabetes. Most people know it as a weekly pen. There’s also a once-daily Ozempic tablet, on a separate label shared with Rybelsus. This guide follows the FDA labels (Revised: 5/2026 (DailyMed version 20) for the injection) and our price records, which also drive the cost calculator.

What is Ozempic used for?

Every approved use is in adults with type 2 diabetes. The label lists:

  • Blood sugar control. Along with diet and exercise, to improve glycemic (blood sugar) control (injection and tablets).
  • Cardiovascular risk. To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease (injection), or who are at high risk for these events (tablets).
  • Kidney disease. To reduce the risk of sustained eGFR decline (a lasting drop in a measure of kidney function), end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (injection).

Is Ozempic approved for weight loss?

No weight-loss use appears among Ozempic’s indications, the uses it’s approved for. The semaglutide product whose label covers long-term weight reduction is Wegovy, which has its own doses and its own prices. The Wegovy label says using it together with other semaglutide products isn’t recommended, so the two aren’t taken together.

What forms and doses does Ozempic come in?

Ozempic pen doses

The pen delivers weekly doses of 0.25 mg, 0.5 mg, 1 mg, 2 mg. The label’s path is:

  1. 0.25 mg once weekly for 4 weeks. This is the initiation (starting) dosage.
  2. 0.5 mg once weekly. The first maintenance dosage, meaning a dose you can stay on.
  3. 1 mg once weekly, if more blood sugar control is needed after at least 4 weeks on 0.5 mg.
  4. 2 mg once weekly, if more blood sugar control is needed after at least 4 weeks on 1 mg. The maximum recommended dosage is 2 mg once weekly.

For adults with type 2 diabetes and chronic kidney disease, the label’s maintenance dosage is 1 mg, reached after at least 4 weeks on 0.5 mg. Whether and when you move up is your prescriber’s decision. The titration schedule tool lays the steps out on a calendar.

How many doses are in an Ozempic pen?

The pens are multi-dose, and there are three of them:

  • The 2 mg/3 mL pen delivers 4 doses of 0.25 mg and 2 doses of 0.5 mg, or 4 doses of 0.5 mg.
  • The 4 mg/3 mL pen delivers 4 doses of 1 mg.
  • The 8 mg/3 mL pen delivers 4 doses of 2 mg.

At a steady dose, that’s one pen for four weekly injections. NovoFine Plus 32G 4 mm disposable needles come with the pen, and the label says to use a new needle for each injection. An Ozempic pen is for one patient only. It must never be shared, even with a new needle, because sharing risks passing on blood-borne infections.

Ozempic tablets

Ozempic tablets come in strengths of 1.5 mg, 4 mg, 9 mg, taken once daily. The schedule on the shared label starts at 1.5 mg for days 1 through 30, a dose the label says isn’t effective for glycemic control. It rises to 4 mg for days 31 to 60. From day 61, the dose may go to 9 mg if more blood sugar control is needed.

Two points about the tablets are easy to miss. First, the label says the effectiveness of Ozempic tablets rests on the clinical studies of Rybelsus. Second, Ozempic tablets and Rybelsus can’t be swapped milligram for milligram, even though both are semaglutide tablets. The strengths are different numbers for a reason.

The label also describes a move from the pen: patients on the 0.5 mg injection can switch to Ozempic tablets 4 mg or 9 mg, starting one week after the last injection. It gives no instruction for other injection doses.

How do you take Ozempic?

How often do you take Ozempic?

You inject it once a week, on the same day each week, at any time of day, with or without meals. If you need a different day, the label allows the change as long as the time between two doses is at least 2 days (more than 48 hours).

Where to inject Ozempic

Inject under the skin of your abdomen, thigh or upper arm. If you stay in the same body region, use a different injection site each week. If you take insulin as well, the label says to give the two as separate injections and never mix them. They may go in the same body region, but the injections shouldn’t be right next to each other.

After each injection, remove the needle and throw it away safely, and store the pen without a needle attached. Used pens and needles go into an FDA-cleared sharps disposal container.

How to take Ozempic tablets

Take one tablet in the morning on an empty stomach, with up to 4 ounces of water and no other liquid. Then wait at least 30 minutes before you eat, drink anything else or take other oral medicines.

What does Ozempic do, and how well does it work?

The label reports results trial by trial, and each figure belongs to its own trial.

  • Blood sugar. In a 30-week trial of Ozempic used alone, HbA1c (a measure of average blood sugar) changed by -1.4% with Ozempic 0.5 mg and -1.6% with 1 mg, versus -0.1% with placebo. In a 40-week trial, HbA1c changed by -2.1% with 2 mg versus -1.9% with 1 mg.
  • Body weight. In that 30-week trial, mean (average) weight change was -3.8 kg with 0.5 mg and -4.7 kg with 1 mg, versus -1.2 kg with placebo. In the 40-week trial, the change was -6.4 kg with 2 mg and -5.6 kg with 1 mg, a difference the label says was not statistically significant.
  • Heart. In SUSTAIN 6, a trial of 3,297 patients followed for a median of 2.1 years, Ozempic reduced major adverse cardiovascular events, with a hazard ratio of 0.74. (A hazard ratio compares risk between two groups.) Events occurred in 6.6% of patients on Ozempic and 8.9% on placebo.
  • Kidneys. In the FLOW trial of 3,533 patients with type 2 diabetes and chronic kidney disease, followed for a median of 41 months, Ozempic 1 mg reduced the primary kidney composite endpoint (the trial’s main combined kidney measure), with a hazard ratio of 0.76.

These are group averages in people with type 2 diabetes. They don’t predict an individual result.

How much is Ozempic?

It depends on how you pay. The prices for the pen are:

  • Self-pay, 0.25 mg, 0.5 mg or 1 mg. $349 a month through NovoCare Pharmacy or the self-pay offer at a retail pharmacy.
  • Self-pay, new patients. $199 a month for the first two monthly fills of 0.25 mg or 0.5 mg, through December 31, 2026, then $349.
  • Self-pay, 2 mg. $499 a month.
  • Commercial insurance that covers Ozempic. As little as $25 with the savings offer.
  • List price. $1,027.51 per pen. This is the full price before any discount. Novo Nordisk has announced a lower list price effective January 1, 2027.

A month in these offers is one box containing one pen. TrumpRx lists the same self-pay prices and issues a coupon for a retail pharmacy.

The Ozempic cost page has the full breakdown, a year’s total and the conditions on each offer. For the wider picture, see our guides to GLP-1 costs and savings cards.

The Ozempic $25 savings card

The savings offer applies only when commercial insurance covers Ozempic. If you’re eligible, you pay as little as $25 for a 1-, 2- or 3-month prescription, up to a maximum saving per month, and you can use the offer for up to 48 months. Government beneficiaries are excluded, which rules out Medicare and Medicaid.

Does insurance or Medicare cover Ozempic?

Coverage for type 2 diabetes is common, but plans differ on prior authorization (the plan’s approval before it pays) and on which medicines you must try first. Call the number on your insurance card and ask about Ozempic for your diagnosis. If you’re denied, the appeal letter generator drafts a request for your prescriber.

For Medicare, CMS lists type 2 diabetes as an indication eligible for Part D coverage. It says people with a GLP-1 prescription for a covered indication should keep getting it through their Part D plan. Ozempic isn’t one of the products in the Medicare GLP-1 Bridge, which is for weight management, and a diagnosis of type 2 diabetes rules a person out of the Bridge in any case.

Under the Medicare Drug Price Negotiation Program, CMS and Novo Nordisk agreed a negotiated price of $274 for a 30-day supply of semaglutide (Ozempic, Rybelsus, Wegovy) for 2027, against a 2024 list price of $959, a 71% discount. It takes effect January 1, 2027. What you pay at the counter will still depend on your plan’s cost sharing. The Medicare guide covers the rest.

What are the side effects of Ozempic?

The common ones are gastrointestinal (stomach and bowel). In the label’s placebo-controlled trials, nausea was reported by 15.8 percent of patients on 0.5 mg and 20.3 percent on 1 mg, against 6.1 percent on placebo. Vomiting was reported by 5 percent and 9.2 percent (placebo 2.3 percent), and diarrhea by 8.5 percent and 8.8 percent (placebo 1.9 percent). Taken together, gastrointestinal reactions occurred in 32.7% of patients on 0.5 mg and 36.4% on 1 mg, compared with 15.3% on placebo. The label says most reports of nausea, vomiting or diarrhea came during dose escalation, while the dose was going up. More patients on Ozempic 0.5 mg (3.1%) and 1 mg (3.8%) than on placebo (0.4%) stopped treatment because of gastrointestinal reactions.

Low blood sugar is mainly a concern when Ozempic is combined with insulin or a sulfonylurea. The label says to consider reducing the dose of those medicines when starting Ozempic. Your prescriber makes that adjustment.

Ozempic and hair loss

Hair loss isn’t in the Ozempic label’s clinical trial tables. It appears in the list of reactions reported after approval. The label notes that such reports come voluntarily from a population of uncertain size, so a frequency can’t be reliably estimated and a causal relationship isn’t established. In short, the label records reports of hair loss and gives no rate.

“Ozempic face”

This phrase doesn’t appear in the label. It’s a fair question to bring to your prescriber.

The boxed warning

Ozempic carries a boxed warning about thyroid C-cell tumors. In plain words: semaglutide caused thyroid C-cell tumors in rodents, and it’s unknown whether Ozempic causes them, including medullary thyroid carcinoma (MTC), in humans. Ozempic is contraindicated, meaning it must not be used, in people with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and after a serious hypersensitivity (allergic) reaction to semaglutide or any ingredient.

The label’s other warnings cover acute pancreatitis, diabetic retinopathy complications, low blood sugar with insulin or sulfonylureas, acute kidney injury from dehydration, severe gastrointestinal reactions, serious allergic reactions, acute gallbladder disease, and aspiration (stomach contents entering the lungs) during general anesthesia or deep sedation. On retinopathy, a 2-year trial found complications in 3.0% of patients on Ozempic and 1.8% on placebo. Tell your healthcare providers you take Ozempic before any planned surgery or procedure. The label also says to stop Ozempic at least 2 months before a planned pregnancy.

Contact a clinician promptly if you have severe abdominal pain that doesn’t go away, changes in vision, or signs of an allergic reaction.

What if I miss a dose of Ozempic?

For the injection, the label’s rule depends on how long ago the missed dose was due. If 5 days or fewer have passed, take it as soon as possible. If more than 5 days have passed, skip the missed dose and take the next one on your regularly scheduled day. Either way, you then go back to your usual once-weekly schedule.

For Ozempic tablets, skip the missed dose and take the next dose the following day.

The missed dose tool applies the rule to your dates.

How do I store Ozempic?

Before first use. Keep the pen in a refrigerator at 36°F to 46°F (2°C to 8°C). Don’t store it in the freezer or directly next to the refrigerator’s cooling element.

After first use. You can store the pen for 56 days at room temperature, 59°F to 86°F (15°C to 30°C), or in a refrigerator. Keep the cap on when you’re not using it, and protect it from excessive heat and sunlight. Throw the pen away after 56 days, even if medicine is left in it.

Always. Don’t freeze Ozempic, and don’t use it if it has been frozen.

Tablets. Store Ozempic tablets at 68°F to 77°F (20°C to 25°C) in the original bottle.

The supply tracker can keep count of doses left in a pen and the 56-day limit.

How does Ozempic compare with other options?

Ozempic is one of several GLP-1 medicines approved for type 2 diabetes, alongside Mounjaro, Trulicity and Rybelsus. Their labels differ in approved uses, dose steps and device. The trials behind them weren’t run head to head, so a label comparison can’t tell you which is more effective for you. The switching planner shows what each label says about moving from one to another. The Ozempic injection label itself gives no instructions for switching from another GLP-1 medicine. It only gives the starting dose.

Frequently asked questions

How much is Ozempic?

If you pay cash through NovoCare Pharmacy, Ozempic is $349 a month for the 0.25 mg, 0.5 mg or 1 mg dose and $499 a month for 2 mg. If you're a new self-pay patient, you pay $199 for each of your first two monthly fills of 0.25 mg or 0.5 mg through December 31, 2026. The list price is $1,027.51 per pen.

How does the Ozempic $25 savings card work?

The Ozempic savings offer is for people with commercial insurance that covers Ozempic. If you're eligible, you pay as little as $25 for a 1-, 2- or 3-month prescription of any pen dose, up to a maximum saving per month, for up to 48 months. If you're on Medicare, Medicaid or other government coverage, you can't use it.

How many doses are in an Ozempic pen?

It depends on the pen. The label says the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg. The 4 mg/3 mL pen delivers 4 doses of 1 mg, and the 8 mg/3 mL pen delivers 4 doses of 2 mg. At a steady weekly dose, one pen is four weeks of treatment.

Where do you inject Ozempic?

The label says to inject Ozempic under the skin of your abdomen, thigh or upper arm. Use a different injection site each week when you inject in the same body region. If you also use insulin, give the two as separate injections and never mix them. They can go in the same body region, but not right next to each other.

How often do you take Ozempic?

You take the injection once a week, on the same day each week, at any time of day, with or without meals. You can change your weekly day if needed, as long as at least 2 days (more than 48 hours) separate two doses. Ozempic tablets are a different form, taken once daily in the morning.

What should I do about a missed dose of Ozempic?

The injection label says to take a missed dose as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip it and take your next dose on your regular day. Either way, you then go back to your usual weekly schedule. For Ozempic tablets, skip the missed dose and take the next one the following day.

Does Ozempic cause hair loss?

The Ozempic label's clinical trial tables don't list hair loss. Hair loss (alopecia) appears only among reactions reported after approval. The label says the frequency of such voluntary reports can't be reliably estimated and a causal link isn't established. So the label records a report of it without a rate.

What is Ozempic face?

It's a popular phrase, not a term in the FDA label. If you notice changes that worry you while taking Ozempic, bring them up with your prescriber.

Does Medicare cover Ozempic?

CMS lists type 2 diabetes as an indication eligible for Part D coverage, so Part D plans can cover Ozempic for it, subject to each plan's formulary and rules. Ozempic isn't part of the Medicare GLP-1 Bridge. From January 1, 2027, the negotiated Medicare price for semaglutide is $274 for a 30-day supply.

Is Ozempic a GLP-1, and who makes it?

Yes. Ozempic is semaglutide, a GLP-1 medicine made by Novo Nordisk. It's one of several GLP-1 medicines approved for type 2 diabetes, alongside Mounjaro, Trulicity and Rybelsus. You take it as a once-weekly injection or a once-daily tablet.

Is Ozempic insulin?

No. Ozempic is semaglutide, a GLP-1 medicine, and it isn't insulin. The label treats insulin as a separate product. If you use both, they're given as separate injections and never mixed, and the label says to consider reducing the insulin dose when starting Ozempic.

Sources (34)

  1. 1.
    FDA label (DailyMed): Ozempic prescribing information, section 2.1
    “Administer OZEMPIC once weekly, on the same day each week, at any time of the day, with or without meals.”
  2. 2.
    FDA label (DailyMed): Ozempic prescribing information, section 2.1
    “Inject OZEMPIC subcutaneously in the abdomen, thigh, or upper arm. Instruct patients to use a different injection site each week when injecting in the same body region.”
  3. 3.
    FDA label (DailyMed): Ozempic prescribing information, section 2.1
    “When using OZEMPIC with insulin, instruct patients to administer as separate injections and to never mix the products. It is acceptable to inject OZEMPIC and insulin in the same body region, but the injections should not be adjacent to each other.”
  4. 4.
    FDA label (DailyMed): Ozempic prescribing information, section 2.1
    “The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours).”
  5. 5.
    FDA label (DailyMed): Ozempic prescribing information, section 16
    “Prior to first use, the OZEMPIC pen should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F). Do not store in the freezer or directly adjacent to the refrigerator cooling element.”
  6. 6.
    FDA label (DailyMed): Ozempic prescribing information, section 16
    “After first use of the OZEMPIC pen, the pen can be stored for 56 days at controlled room temperature 15°C to 30°C (59°F to 86°F) or in a refrigerator 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen cap on when not in use. OZEMPIC should be protected from excessive heat and sunlight.”
  7. 7.
    FDA label (DailyMed): Ozempic prescribing information, section 16
    “Do not freeze OZEMPIC and do not use OZEMPIC if it has been frozen. OZEMPIC must be kept in the original carton until time of administration.”
  8. 8.
    FDA label (DailyMed): Ozempic prescribing information, section 3
    “Injection: 2 mg/3 mL (0.68 mg/mL) for 4 doses of 0.25 mg and 2 doses of 0.5 mg or 4 doses of 0.5 mg, 4 mg/3 mL (1.34 mg/mL) for 4 doses of 1 mg, and 8 mg/3 mL (2.68 mg/mL) for 4 doses of 2 mg in single-patient-use pens”
  9. 9.
    FDA label (DailyMed): Ozempic prescribing information, section 16
    “Always remove and safely discard the needle after each injection and store the OZEMPIC pen without an injection needle attached. Always use a new needle for each injection.”
  10. 10.
    FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
    “NovoFine® Plus 32G 4 mm disposable needles are included with your OZEMPIC pen.”
  11. 11.
    FDA label (DailyMed): Ozempic prescribing information, section 16
    “Each OZEMPIC multi-dose pen is for use by a single patient. An OZEMPIC pen must never be shared between patients, even if the needle is changed”
  12. 12.
    FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
    “The OZEMPIC pen you are using should be disposed of (thrown away) after 56 days, even if it still has OZEMPIC left in it.”
  13. 13.
    FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
    “Put your used OZEMPIC pen and needle in a FDA-cleared sharps disposal container right away after use.”
  14. 14.
    FDA label (DailyMed): Ozempic prescribing information, section 8.3
    “Discontinue OZEMPIC in women at least 2 months before a planned pregnancy due to the long washout period for semaglutide”
  15. 15.
    FDA label (DailyMed): Ozempic prescribing information, section 7.1
    “When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia”
  16. 16.
    FDA label (DailyMed): Ozempic prescribing information, section 14.1, Table 3
    “Monotherapy with OZEMPIC 0.5 mg and 1 mg once weekly for 30 weeks resulted in a statistically significant reduction in HbA1c compared with placebo”
  17. 17.
    FDA label (DailyMed): Ozempic prescribing information, section 14.1
    “The mean changes from baseline to week 30 were -1.2 kg, -3.8 kg and -4.7 kg in the placebo, OZEMPIC 0.5 mg, and OZEMPIC 1 mg arms, respectively.”
  18. 18.
    FDA label (DailyMed): Ozempic prescribing information, section 14.1, Table 7
    “The mean changes from baseline to week 40 were -5.6 kg and -6.4 kg in the OZEMPIC 1 mg and OZEMPIC 2 mg arms, respectively. The difference between treatment arms in body weight change from baseline at week 40 was not statistically significant.”
  19. 19.
    FDA label (DailyMed): Ozempic prescribing information, section 14.2
    “OZEMPIC significantly reduced the occurrence of MACE. The estimated hazard ratio for time to first MACE was 0.74 (95% CI: 0.58, 0.95).”
  20. 20.
    FDA label (DailyMed): Ozempic prescribing information, section 14.3
    “OZEMPIC was superior to placebo in reducing the incidence of the primary composite endpoint of a sustained decline in eGFR of ≥50%, sustained eGFR <15 mL/min/1.73m2, chronic renal replacement therapy, renal death, CV death (HR 0.76 [95% CI 0.66, 0.88], p=0.0003) as shown in Table 10 and Figure 7.”
  21. 21.
    FDA label (DailyMed): Ozempic prescribing information, section 4
    “A personal or family history of MTC or in patients with MEN 2”
  22. 22.
    FDA label (DailyMed): Ozempic prescribing information, section 4
    “A serious hypersensitivity reaction to semaglutide or to any of the excipients in OZEMPIC. Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with OZEMPIC”
  23. 23.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
    “Take one RYBELSUS or OZEMPIC tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces of water). Do not take RYBELSUS or OZEMPIC tablets with other liquids besides water”
  24. 24.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
    “After taking RYBELSUS or OZEMPIC tablets, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
  25. 25.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
    “RYBELSUS and OZEMPIC tablets are not substitutable on a mg-to-mg basis.”
  26. 26.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.2
    “Starting Dosage (Initiation Phase) (Days 1 through 30): The recommended starting dosage is 1.5 mg orally once daily (this dosage is not effective for glycemic control).”
  27. 27.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.4
    “One week after discontinuing 0.5 mg of subcutaneous OZEMPIC injection, start 4 mg or 9 mg of OZEMPIC tablets orally once daily.”
  28. 28.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 14.1
    “has been established as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus based on adequate and well-controlled studies of RYBELSUS in adult patients with type 2 diabetes mellitus”
  29. 29.
    FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 16
    “Store RYBELSUS and OZEMPIC tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store and dispense in the original bottle.”
  30. 30.
    CMS: Information for Part D Plans
    “Type 2 diabetes, moderate to severe obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis) indications are eligible for Part D coverage. [...] If a Medicare Part D beneficiary has a prescription for a GLP-1 drug for an indication covered under Medicare Part D, they should continue to obtain their GLP-1 through their Part D plan.”
  31. 31.
    CMS: Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2027
    “Below is the list of negotiated prices, which the statute refers to as maximum fair prices (MFPs), for the 15 selected drugs covered under Medicare Part D that will go into effect beginning January 1, 2027, based on negotiations and agreements reached between CMS and participating drug companies. [table] Drug Name: Ozempic; Rybelsus; Wegovy. Participating Drug Company: Novo Nordisk Inc. Agreed to Negotiated Price for 30-day Supply for CY 2027: $274. List Price for 30-day Supply, CY 2024: $959. Discount of Negotiated Price from 2024 List Price: 71%.”
  32. 32.
  33. 33.
  34. 34.